Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Eur J Pain ; 16(10): 1357-67, 2012 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-22467279

RESUMO

BACKGROUND: Peripheral nerve injury is associated with a spinal microglial response that has been correlated with the development of behaviours reflective of neuropathic pain. METHODS: To examine whether this phenomenon is generalizable to neuropathic pain of non-traumatic aetiology, this study investigated the association between spinal microgliosis and behavioural measures of neuropathic hypersensitivity and pain-related anxiety behaviour in four distinct rat models of peripheral neuropathic pain. These were traumatic neuropathy [L5 spinal nerve transection (SNT)], HIV-related neuropathies (either treatment with the antiretroviral drug Zalcitabine (ddC) or combination of perineural exposure to the HIV-gp120 protein and ddC treatment) and varicella zoster virus (VZV) infection. RESULTS AND CONCLUSION: Persistent mechanical hypersensitivity developed in all 'neuropathic' rats. However, spinal microgliosis, as measured by increased CD11b/c immunohistochemical staining and increased numbers of cells expressing CD11b measured by flow cytometry, was evident in the SNT and to a lesser extent in the HIV neuropathy models but not the VZV model. These results suggest that behavioural hypersensitivity and thigmotaxis can only be linked to a microglial response in certain models of neuropathy.


Assuntos
Comportamento Animal , Gliose/patologia , Microglia/patologia , Doenças do Sistema Nervoso Periférico/patologia , Medula Espinal/patologia , Animais , Fármacos Anti-HIV/efeitos adversos , Modelos Animais de Doenças , Citometria de Fluxo , Proteína gp120 do Envelope de HIV/efeitos adversos , Infecções por HIV/complicações , Infecções por HIV/patologia , Herpes Zoster/complicações , Herpes Zoster/patologia , Herpesvirus Humano 3 , Hiperalgesia/patologia , Imuno-Histoquímica , Masculino , Traumatismos dos Nervos Periféricos/complicações , Traumatismos dos Nervos Periféricos/patologia , Doenças do Sistema Nervoso Periférico/etiologia , Ratos , Ratos Wistar , Nervos Espinhais/lesões , Zalcitabina/efeitos adversos
2.
Anaesthesia ; 65(1): 27-35, 2010 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-19889110

RESUMO

Reduced HLA-DR expression on monocytes has been suggested as a predictive marker of immunosuppression following very high risk surgery, but there are few reports in lower risk surgery. In 32 patients undergoing low to intermediate risk surgery, blood samples were analysed by flow cytometry for HLA-DR expression and numbers in both CD14(high) and CD14(low)CD16+ monocyte subsets. The numbers of CD14(high) monocytes increased at 24 h (mean (SD), 5.0 (2.2) vs 7.6 (3.9) x 10(5) cells.ml(-1); p < 0.01) while CD14(low)CD16+ monocytes decreased (0.68 (0.36) vs 0.44 (0.36) x 10(5) cells.ml(-1); p < 0.01). HLA-DR expression was significantly reduced in both subsets by 24 h (mean (SD) fluorescent intensity 440 (310) vs 160 (130) for CD14(high) and 1000 (410) vs 560 (380) for CD14(low)CD16+ subsets; p < 0.01). This reduction of monocyte HLA-DR expression 24 h following lower risk surgery raises questions about the purported clinical utility of this biomarker as an early predictor of postoperative complications. Our results also suggest that surgery induces significant trafficking (i.e. mobilisation, margination and extravasation) of monocyte subsets, and that monocyte HLA-DR depression is the result of a down-regulatory phenomenon (decreased protein expression on each cell) rather than the differential trafficking of monocyte subsets.


Assuntos
Antígenos HLA-DR/sangue , Monócitos/imunologia , Procedimentos Cirúrgicos Operatórios , Abdome/cirurgia , Adulto , Idoso , Idoso de 80 Anos ou mais , Artroplastia de Substituição , Cirurgia Bariátrica , Feminino , Citometria de Fluxo/métodos , Humanos , Tolerância Imunológica/imunologia , Contagem de Leucócitos , Masculino , Pessoa de Meia-Idade , Período Pós-Operatório , Estudos Prospectivos
3.
J Neurosci Methods ; 164(2): 207-17, 2007 Aug 30.
Artigo em Inglês | MEDLINE | ID: mdl-17553569

RESUMO

Microgliosis is implicated in the pathophysiology of several neurological disorders, including neuropathic pain. Consequently, perturbation of microgliosis is a mechanistic and drug development target in neuropathic pain, which highlights the requirement for specific, sensitive and reproducible methods of microgliosis measurement. In this study, we used the spinal microgliosis associated with L5 spinal nerve transection and minocycline-induced attenuation thereof to: (1) evaluate novel software based semi-quantitative image analysis paradigms for the assessment of immunohistochemical images. Microgliosis was revealed by immunoreactivity to OX42. Several image analysis paradigms were assessed and compared to a previously validated subjective categorical rating scale. This comparison revealed that grey scale measurement of the proportion of a defined area of spinal cord occupied by OX42 immunoreactive cells is a robust image analysis paradigm. (2) Develop and validate a flow cytometric approach for quantification of spinal microgliosis. The flow cytometric technique reliably quantified microgliosis in spinal cord cell suspensions, using OX42 and ED9 immunoreactivity to identify microglia. The results suggest that image analysis of immunohistochemical revelation of microgliosis reliably detects the spinal microgliosis in response to peripheral nerve injury and pharmacological attenuation thereof. In addition, flow cytometry provides an alternative approach for quantitative analysis of spinal microgliosis elicited by nerve injury.


Assuntos
Diagnóstico por Imagem/métodos , Citometria de Fluxo/métodos , Imuno-Histoquímica/métodos , Microglia/patologia , Doenças do Sistema Nervoso Periférico/patologia , Medula Espinal/patologia , Animais , Antibacterianos/uso terapêutico , Antígenos de Diferenciação/metabolismo , Antígeno CD11b/metabolismo , Lateralidade Funcional , Masculino , Microglia/efeitos dos fármacos , Microglia/metabolismo , Minociclina/uso terapêutico , Doenças do Sistema Nervoso Periférico/tratamento farmacológico , Ratos , Ratos Wistar , Reprodutibilidade dos Testes , Software , Medula Espinal/efeitos dos fármacos , Estatísticas não Paramétricas
4.
Parasite Immunol ; 18(4): 165-72, 1996 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-9223171

RESUMO

During the course of chronic malaria infection antigenic variants of a parasite antigen are expressed and exposed on the surface of infected erythrocyte membranes. There also exists a number of apparently invariant single gene copy blood-stage antigens, exposed or non-exposed, which have been shown to afford immunity under experimental conditions. To determine why the host, presented with invariant 'protective' antigens, is unable to control infections effectively, immunity to a representative single gene copy antigen, the merozoite surface protein 1 (MSP1) was investigated in Plasmodium chabaudi chabaudi AS, a murine model of chronic malaria. Immunization with monoclonal antibody affinity purified native MSP1 resulted in enhanced control of parasitaemia on challenge, irrespective of the parasite inoculum size; challenge with a single parasite, however, suggested that expansion of resistant parasite subpopulations was not occurring. Challenge of mice immunized with recombinant fusion proteins encoding N- or C-terminal regions of the P.c. chabaudi AS MSP1 produced inconsistent effects, often parasitaemias were indistinguishable from controls despite significant anti-MSP1 antibody responses. The not unlikely contamination of MSP1 native preparations with erythrocyte (E) components was considered. Immunization with a mixture of the MSP1 C-terminus recombinant polypeptide and a Triton X-100 solubilized lysate of normal E resulted in enhanced control of parasitaemia, however, no effect was seen after administration of either component on its own. Co-immunization of E with the N-terminus polypeptide reversed the inhibition seen, on this occasion with this construct alone.


Assuntos
Antígenos de Protozoários/genética , Antígenos de Superfície/genética , Genes de Protozoários , Malária/imunologia , Plasmodium chabaudi/genética , Plasmodium chabaudi/imunologia , Animais , Variação Antigênica , Eritrócitos/imunologia , Eritrócitos/parasitologia , Imunização , Malária/parasitologia , Masculino , Proteína 1 de Superfície de Merozoito , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Endogâmicos C57BL , Camundongos Endogâmicos CBA , Parasitemia/imunologia , Plasmodium chabaudi/crescimento & desenvolvimento , Precursores de Proteínas/genética , Precursores de Proteínas/imunologia , Proteínas de Protozoários/genética , Proteínas de Protozoários/imunologia , Proteínas Recombinantes/imunologia , Fatores de Tempo
5.
Mol Biochem Parasitol ; 72(1-2): 111-9, 1995 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-8538682

RESUMO

Processing of the Plasmodium merozoite surface protein 1 (MSP-1) has been described for parasites maintained under in vitro conditions. We have now demonstrated, using CBA/Ca mice infected with Plasmodium chabaudi chabaudi AS, that MSP-1 processing also occurs in vivo. The major proteolytic cleavage sites and a processing scheme were deduced from N-terminal amino-acid sequences of the MSP-1 breakdown products. Comparison of MSP-1 processing in P. falciparum and P.c. chabaudi indicates a degree of conservation and in two cases the position of protease cleavage appears identical. Significant amounts of MSP-1 polypeptides are found in plasma during schizogony. Various aspects of MSP-1 processing including immunological and physiological reactions in the host during the critical period of schizogony can now be examined in vivo.


Assuntos
Antígenos de Protozoários/metabolismo , Plasmodium chabaudi/metabolismo , Precursores de Proteínas/metabolismo , Proteínas de Protozoários/metabolismo , Sequência de Aminoácidos , Animais , Endopeptidases/metabolismo , Malária/parasitologia , Proteína 1 de Superfície de Merozoito , Camundongos , Dados de Sequência Molecular , Parasitemia/parasitologia , Plasmodium chabaudi/crescimento & desenvolvimento , Plasmodium chabaudi/imunologia , Plasmodium chabaudi/isolamento & purificação , Plasmodium falciparum/metabolismo , Alinhamento de Sequência , Homologia de Sequência de Aminoácidos , Especificidade da Espécie
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA